tiprankstipranks
Trending News
More News >
vTv Therapeutics (VTVT)
NASDAQ:VTVT
US Market

vTv Therapeutics (VTVT) Financial Statements

Compare
780 Followers

vTv Therapeutics Financial Overview

vTv Therapeutics's market cap is currently $148.73M. The company's EPS TTM is $-1.08; its P/E ratio is -10.71; vTv Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-1.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.02M$ 0.00$ 2.02M$ 4.00M$ 6.41M
Gross Profit$ 1.02M$ 0.00$ 2.02M$ 4.00M$ -4.60M
Operating Income$ -24.18M$ -25.50M$ -22.54M$ -21.66M$ -11.85M
EBITDA$ -22.52M$ -25.86M$ -24.77M$ -17.52M$ -12.02M
Net Income$ -18.46M$ -20.25M$ -19.16M$ -12.99M$ -8.50M
Balance Sheet
Cash & Short-Term Investments$ 36.75M$ 9.45M$ 12.13M$ 13.41M$ 5.75M
Total Assets$ 38.27M$ 11.02M$ 33.24M$ 25.47M$ 14.79M
Total Debt$ 169.00K$ 529.00K$ 716.00K$ 932.00K$ 915.00K
Net Debt$ -36.58M$ -8.92M$ -11.41M$ -12.48M$ -4.83M
Total Liabilities$ 23.96M$ 29.57M$ 27.40M$ 10.25M$ 11.00M
Stockholders' Equity$ 12.20M$ -24.68M$ -10.74M$ -9.74M$ -80.10M
Cash Flow
Free Cash Flow$ -25.31M$ -19.08M$ -15.27M$ -19.31M$ -18.00M
Operating Cash Flow$ -25.31M$ -19.08M$ -15.25M$ -19.31M$ -18.00M
Investing Cash Flow$ 0.00$ 4.40M$ -21.00K$ 0.00$ 0.00
Financing Cash Flow$ 52.61M$ 12.00M$ 13.98M$ 26.98M$ 19.47M
Currency in USD

vTv Therapeutics Earnings and Revenue History

vTv Therapeutics Debt to Assets

vTv Therapeutics Cash Flow

vTv Therapeutics Forecast EPS vs Actual EPS